Key Facts

  • Lilly at a Glance

    • A heritage more than 140 years strong: company founded on May 10, 1876
    • Headquarters located in Indianapolis, Indiana, U.S.A.
    • Approximately 40,000 employees worldwide
    • More than 8,000 employees engaged in research and development
    • Clinical research conducted in more than 55 countries
    • Research and development facilities located in six countries
    • Manufacturing plants located in 13 countries
    • Products marketed in 120 countries
  • Employees

    (as of December 31, 2017)

    • Indianapolis: 11,402
    • Indiana (excluding Indianapolis): 1,208
    • U.S. (excluding Indiana): 5,811
    • Outside U.S.: 22,235
    • Worldwide total: 40,656
  • 2017 Financials

    (dollars in millions, except per-share data)

    • Net sales: $22,871.3
    • Net income (loss) as reported: -$204.1
    • Net income non-GAAP: $4,530.4
    • Earnings (loss) per share as reported: -$0.19
    • Earnings per share non-GAAP: $4.28
    • Dividends paid per share: $2.08
  • Research & Development

    2017 Expenditures

    • $5,281.8 million/year
    • $440 million/month
    • $102 million/week
    • $20 million/workday
    • R&D as a percentage of sales: 24.7%
    • Employees engaged in R&D activities: 8,981
    • Percentage of total workforce: 22%
  • Cost of Pharmaceuticals

    • Average cost to discover and develop a new drug: $2.6 billion
    • Average length of time from discovery to patient: 10 years